Mice don’t get Alzheimer’s-;and while that’s good news for mice, it’s a big problem for biomedical researchers seeking to understand the disease and test new treatments.
KT-253 by Kymera Therapeutics for Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia): Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes
November 5, 2023